MacroGenics
MGNX • NASDAQ
MacroGenics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric Blasius Risser, with a market cap of $186.2M.
CEOEric Blasius Risser
Next Earnings
Upcoming earnings announcement for MacroGenics
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.47
Revenue Estimate
$17.4M
Earnings History
Past 12 earnings reports for MacroGenics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$0.22Est: -$0.18 | -22.2% | $41.2MEst: $26.3M | +56.7% |  10-K |
| Nov 12, 2025 | Q3 2025 | $0.27Est: -$0.39 | +169.2% | $72.8MEst: $28.6M | +155.1% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.57Est: -$0.01 | -5600.0% | $22.2MEst: $25.3M | -12.2% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.65Est: -$0.69 | +5.8% | $13.2MEst: $9.6M | +37.6% | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.25Est: -$0.59 | +57.6% | $19.4MEst: $34.2M | -43.4% | 10-K |
| Nov 5, 2024 | Q3 2024 | $0.90Est: $0.21 | +328.6% | $110.7MEst: $76.1M | +45.5% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.89Est: -$0.59 | -50.8% | $10.8MEst: $21.2M | -49.2% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.84Est: -$0.64 | -31.2% | $9.1MEst: $14.6M | -37.7% | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.75Est: -$0.15 | -400.0% | $10.7M | — | 10-K |
| Nov 6, 2023 | Q3 2023 | $0.28Est: -$0.10 | +380.0% | $10.4MEst: $48.9M | -78.7% | — |
| Aug 9, 2023 | Q2 2023 | $0.92Est: -$0.52 | +276.9% | $13.1MEst: $29.7M | -55.8% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.61Est: $0.45 | -235.6% | $24.5MEst: $86.5M | -71.7% | — |